Researchers assessed the safety, biologic, and clinical effects of low-dose interleukin-2 across 11 individual diseases chosen to represent the whole spectrum of autoimmune or inflammatory chronic diseases.
Severe gastrointestinal disease is common in early systemic sclerosis, and is linked to increased mortality.
Researchers evaluated the Montreal Cognitive Assessment questionnaire and the Informant Questionnaire on Cognitive Decline in the Elderly as screening tools for cognitive dysfunction in SLE.
The presence of the FCGR2A rs1801274-TT genotype and FCGR3A rs396991-G allele may act as significant predictors of response to tocilizumab and rituximab therapy in RA.
Researchers observed a significant reduction in the incidence of acute anterior uveitis among patients with ankylosing spondylitis treated with golimumab.
Ultrasound effusion and synovial hypertrophy differ by gender in community-derived people without painful knee OA.
Poor vitamin K status is associated with inflammation and low areal bone mineral density (BMD) among patients with end-stage renal disease.
In patients with rheumatoid arthritis, the use of multiple antibody assays may improve clinical diagnosis and disease management.
Investigators examined the effect of an interdisciplinary, combined intervention in patients with hand osteoarthritis.
Data regarding assessment of systemic inflammation using acute-phase reactants are limited.
